1190 related articles for article (PubMed ID: 19444812)
1. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
[TBL] [Abstract][Full Text] [Related]
2. The presence of small intestinal intraepithelial gamma/delta T-lymphocytes is inversely correlated with lymphoma development in refractory celiac disease.
Verbeek WH; von Blomberg BM; Scholten PE; Kuik DJ; Mulder CJ; Schreurs MW
Am J Gastroenterol; 2008 Dec; 103(12):3152-8. PubMed ID: 19086962
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
Verbeek WH; Goerres MS; von Blomberg BM; Oudejans JJ; Scholten PE; Hadithi M; Al-Toma A; Schreurs MW; Mulder CJ
Clin Immunol; 2008 Jan; 126(1):48-56. PubMed ID: 18024205
[TBL] [Abstract][Full Text] [Related]
4. Decreased circulating iNKT cell numbers in refractory coeliac disease.
Bernardo D; van Hoogstraten IM; Verbeek WH; Peña AS; Mearin ML; Arranz E; Garrote JA; Scheper RJ; Schreurs MW; Bontkes HJ; Mulder CJ; von Blomberg BM
Clin Immunol; 2008 Feb; 126(2):172-9. PubMed ID: 17974485
[TBL] [Abstract][Full Text] [Related]
5. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype.
de Mascarel A; Belleannée G; Stanislas S; Merlio C; Parrens M; Laharie D; Dubus P; Merlio JP
Am J Surg Pathol; 2008 May; 32(5):744-51. PubMed ID: 18360280
[TBL] [Abstract][Full Text] [Related]
6. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma.
Mulder CJ; Wahab PJ; Moshaver B; Meijer JW
Scand J Gastroenterol Suppl; 2000; (232):32-7. PubMed ID: 11232488
[TBL] [Abstract][Full Text] [Related]
7. The management of complicated celiac disease.
Al-toma A; Verbeek WH; Mulder CJ
Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells promote expansion and survival of aberrant TCR-negative intraepithelial lymphocyte lines from refractory celiac disease type II patients.
Schmitz F; Tjon JM; van Bergen J; Koning F
Mol Immunol; 2014 Mar; 58(1):10-6. PubMed ID: 24252355
[TBL] [Abstract][Full Text] [Related]
9. DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients.
Tjon JM; Kooy-Winkelaar YM; Tack GJ; Mommaas AM; Schreurs MW; Schilham MW; Mulder CJ; van Bergen J; Koning F
J Immunol; 2011 Jun; 186(11):6304-12. PubMed ID: 21525383
[TBL] [Abstract][Full Text] [Related]
10. Refractory coeliac disease.
Daum S; Cellier C; Mulder CJ
Best Pract Res Clin Gastroenterol; 2005 Jun; 19(3):413-24. PubMed ID: 15925846
[TBL] [Abstract][Full Text] [Related]
11. Gluten-free diet induces regression of T-cell activation in the rectal mucosa of patients with celiac disease.
Cellier C; Cervoni JP; Patey N; Leborgne M; Marteau P; Landi B; Cerf-Bensussan N; Barbier JP; Brousse N
Am J Gastroenterol; 1998 Sep; 93(9):1527-30. PubMed ID: 9732937
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte subpopulations in the human small intestine. The findings in normal mucosa and in the mucosa of patients with adult coeliac disease.
Selby WS; Janossy G; Bofill M; Jewell DP
Clin Exp Immunol; 1983 Apr; 52(1):219-28. PubMed ID: 6345034
[TBL] [Abstract][Full Text] [Related]
13. Cladribine therapy in refractory celiac disease with aberrant T cells.
Al-Toma A; Goerres MS; Meijer JW; von Blomberg BM; Wahab PJ; Kerckhaert JA; Mulder CJ
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1322-7; quiz 1300. PubMed ID: 16979946
[TBL] [Abstract][Full Text] [Related]
14. Continual monitoring of intraepithelial lymphocyte immunophenotype and clonality is more important than snapshot analysis in the surveillance of refractory coeliac disease.
Liu H; Brais R; Lavergne-Slove A; Jeng Q; Payne K; Ye H; Liu Z; Carreras J; Huang Y; Bacon CM; Hamoudi RA; Save V; Venkatraman L; Isaacson PG; Woodward J; Du MQ
Gut; 2010 Apr; 59(4):452-60. PubMed ID: 19996326
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in refractory coeliac disease: a review.
Ho-Yen C; Chang F; van der Walt J; Mitchell T; Ciclitira P
Histopathology; 2009 Jun; 54(7):783-95. PubMed ID: 18700844
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.
Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694
[TBL] [Abstract][Full Text] [Related]
17. Pathological and clinical significance of increased intraepithelial lymphocytes (IELs) in small bowel mucosa.
Chang F; Mahadeva U; Deere H
APMIS; 2005 Jun; 113(6):385-99. PubMed ID: 15996156
[TBL] [Abstract][Full Text] [Related]
18. Update on the management of refractory coeliac disease.
Al-Toma A; Verbeek WH; Mulder CJ
J Gastrointestin Liver Dis; 2007 Mar; 16(1):57-63. PubMed ID: 17410290
[TBL] [Abstract][Full Text] [Related]
19. Origin and immunophenotype of aberrant IEL in RCDII patients.
Tack GJ; van Wanrooij RL; Langerak AW; Tjon JM; von Blomberg BM; Heideman DA; van Bergen J; Koning F; Bouma G; Mulder CJ; Schreurs MW
Mol Immunol; 2012 Apr; 50(4):262-70. PubMed ID: 22364936
[TBL] [Abstract][Full Text] [Related]
20. Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II.
Schmitz F; Tjon JM; Lai Y; Thompson A; Kooy-Winkelaar Y; Lemmers RJ; Verspaget HW; Mearin ML; Staal FJ; Schreurs MW; Cupedo T; Langerak AW; Mulder CJ; van Bergen J; Koning F
Gut; 2013 Apr; 62(4):509-19. PubMed ID: 22760007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]